News Briefs Syros Pharmaceuticals snags $53 mln from Polaris, Flagship, ARCH Venture Iris Dorbian - 27 October 2014 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
